Smith & Nephew plc

NYSE:SNN

Medical - Devices

Healthcare
$30.32 -1.39%

-$0.43 today

Market cap
$12.72B
Beta
0.67
P/E (TTM)
20.1
EPS (TTM)
$0.74
Dividend yield
2.59%
52W Low $28.79High $38.79

Volume 1.22M

Average 1.10M

SNN Debt Repayment

Cash used to repay borrowings during the period.

Smith & Nephew plcNYSE: SNN

Debt Repayment · Q4 FY2025 · quarter ended Dec 2025

Debt repayment outflow grows to $0

Q4 FY2025 debt repayment was $0, compared with $0 a year earlier. Over 3 fiscal years it compounded at +48.2% a year.

Context

  • Debt repayment amounted to 2.3% of revenue in FY2025, down 14.0 pp from a year earlier.
  • Debt repayment increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
-$140M-114.8% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-114.8%——
3-year CAGR+48.2%——
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
(140M) USD
Year-over-year change
-114.8%

Debt Repayment vs competitors

How SNN compares with its peers on the latest reported figures

  • SNN's FY2025 debt repayment of $140M is the 2nd largest of the 11 companies compared; the peer median is $11.53M.
  • Its year-over-year change of -114.8% is the 8th highest of 11, against a peer median of -83.5%.
  • Debt repayment amounts to 2.3% of revenue for SNN, versus a peer median of 2.9%.
SNN Competitors Peer median
Debt Repayment for SNN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$2.15B -155.5%+49.6%8.3%
SNNSmith & Nephew plcFY2025$140M -114.8%+48.2%2.3%
ENOVEnovis CorporationLTM Apr 2026$72.43M -269.4%-69.9%3.2%
OFIXOrthofix Medical Inc.LTM Mar 2026$63.42M +115.9%-33.5%7.7%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$51.4M -103.4%—0.6%
CNMDCONMED CorporationLTM Mar 2026$35M -66.0%—2.6%
KIDSOrthoPediatrics Corp.LTM Mar 2026$23.49M -59.9%—9.7%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$21.72M -466.6%+217.7%17.8%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$16.71M +199.0%—1.0%
ATECAlphatec Holdings, Inc.LTM Mar 2026$1.35M -101.0%+30.5%0.2%
GMEDGlobus Medical, Inc.LTM Jun 2026$0 +100.0%—0.0%
Peer median (excluding SNN) $11.53M-83.5%+30.5%2.9%

Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income524M223M263M412M625M
Depreciation & Amortization563M548M527M555M573M
Deferred Income Tax00000
Stock-Based Compensation41M40M39M40M43M
Change in Working Capital(232M)(510M)(227M)(123M)33M
Accounts Receivables(81M)(103M)(49M)(81M)(175M)
Inventory(151M)(407M)(178M)(42M)208M
Accounts Payables00000
Other Working Capital00000
Other Non-Cash Items(19M)167M6M103M11M
Operating Cash Flow877M468M608M987M1.29B
Capital Expenditures(408M)(358M)(427M)(381M)(433M)
Acquisitions (Net)(285M)(113M)(21M)(186M)(9M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities2M(1M)0(2M)36M
Investing Cash Flow(691M)(472M)(448M)(569M)(406M)
Debt Repayment(59M)(43M)(52M)945M(140M)
Common Stock Issued00000
Common Stock Repurchased0(158M)00(502M)
Dividends Paid(329M)(327M)(327M)(327M)(330M)
Other Financing Activities(257M)(398M)179M(704M)17M
Financing Cash Flow(645M)(926M)(200M)(86M)(955M)
Effect of Forex Changes(7M)(11M)(4M)(15M)14.18M
Net Change in Cash(466M)(941M)(44M)317M(62M)
Free Cash Flow469M110M181M606M852M

Smith & Nephew plc

NYSE:SNN

Intrinsic Alpha fair value

Locked

Current Price

$30.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.